Edition:
United Kingdom

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

5.01USD
19 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.01
Open
$5.05
Day's High
$5.05
Day's Low
$5.05
Volume
110
Avg. Vol
4,849
52-wk High
$11.72
52-wk Low
$4.93

Chart for

About

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)

Overall

Beta: --
Market Cap(Mil.): $168.94
Shares Outstanding(Mil.): 13.88
Dividend: --
Yield (%): --

Financials

  ALPN.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -6.42 -- --
ROI: -48.40 0.21 14.27
ROE: -48.40 1.17 15.99

BRIEF-Alpine Immune Sciences Appoints Chris Peetz To Its Board

* ALPINE IMMUNE SCIENCES APPOINTS LIFE SCIENCES EXECUTIVE CHRIS PEETZ TO ITS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

24 Apr 2018

Earnings vs. Estimates